Acurian is a company specializing in providing essential services for patient recruitment and retention in clinical trials. Since its establishment in 1998, the company has been offering support with recruitment feasibility, site identification and selection, patient recruitment and retention, and specialized cancer solutions. Headquartered in Horsham, Pennsylvania, Acurian operates primarily within the Health Care and Pharmaceutical industries.
The company's most recent $3.40M Venture Round investment took place on 08 February 2017, attracting undisclosed investors. Acurian has positioned itself as a key player in the crucial process of patient recruitment and retention for clinical trials, tapping into a market that demands specialized expertise and support.
